TCL Archive Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research January 28, 1994
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004